Find out what’s going up, what’s going down and whether our traders would double down, fade or run in the other direction!
Amazon dropped .
The catalyst: Bank of America Merrill Lynch downgradedthe stock to neutral, saying a "protracted" investment cycle may weigh heavier on the online mega-retailer's bottom line than expected.
The trade: “Over the long-term this is a stock I want to be in,” says trader Patty Edwards. “Betting against Jeff Bezos is a bad move.”
Express Scripts popped .
The catalyst: The FTC approved Express Scripts purchase of rival Medco Health Solutions following an arduous eight-month review.
The trade: “I like the stock,” says Joe Terranova, but not at current levels. I’m a buyer around $52.”
Abercrombie popped .
The catalyst: Brean Murray upgradedthe stock to buy and set a $65 price target, declaring it's time to get "more aggressive" on the name.
The trade: "It’s a quality name – I’m long," reveals trader Mike Murphy. "I think it goes higher."
GDX popped .
The catalyst: Although there’s no clear catalyst, growing chatter in the market suggests the metals may be undervalued.
The trade: Jon Najarian agrees with the chatter and tells us he’d play it long GDX or GDXJ if you want more torque.